(Q44521487)

3 December 2017

title

Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study (English)

1 reference

3 December 2017

1 reference

1 reference

J M Neutel

1

1 reference

3 December 2017

R E Kolloch

2

1 reference

3 December 2017

P F Plouin

3

1 reference

3 December 2017

T W Meinicke

4

1 reference

3 December 2017

H Schumacher

5

1 reference

3 December 2017

OTELLOH Study Group

6

1 reference

3 December 2017

publication date

1 August 2003

1 reference

Journal of Human Hypertension

3 December 2017

published in

1 reference

3 December 2017

volume

17

1 reference

3 December 2017

issue

8

1 reference

3 December 2017

page(s)

569-575

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001592

3 December 2017

exact match

0 references

cites work

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

Telmisartan: a review of its use in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

7 January 2021

Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

7 January 2021

Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

7 January 2021

Implications of small reductions in diastolic blood pressure for primary prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

7 January 2021

Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

7 January 2021

Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001592

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001592

1 reference

3 December 2017

1 reference